BRAZIL’S SCANDALOUS COVAXIN DEAL WITH INDIA

Brazilian President Bolsonaro is facing political crisis due to his mishandling of COVID-19 pandemic which led to 6,00,000 deaths in Brazil.

Investigation of Brazilian Parliamentary Committee (CPI) revealed Bolsonaro administration’s involvement in pending US$ 300mn deal laden with illegitimate and bribery charges to fast track procurement of Bharat Biotech’s Covaxin.

The probe has been focused on why the president pushed for a costly vaccine which was not even approved by the Brazilian drug regulator or WHO?

Reputation and credibility of Indian pharmaceutical company is exposed as evident in Brazilian vaccination procurement case.

It is an example of ingrained corruption and mishandling (white collar crime) in India’s private and government sector.